| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 |
| filingDate |
2017-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2019-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EA-201892311-A1 |
| titleOfInvention |
DERIVATIVES OF 2-ANYLINOPYRIMIDIN AS A THERAPEUTIC AGENTS FOR THE TREATMENT OF BRAIN CANCER |
| abstract |
Methods for using substituted 2-anilinopyrimidine derivatives and their pharmaceutically acceptable salts, solvates or compositions for the treatment of brain cancer, in particular EGFR-mediated metastatic brain cancer, have been proposed. |
| priorityDate |
2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |